Arcutis Biotherapeutics, Inc.
ARQT
45 insider filings · Latest: Sep 16, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 2 11:21 PM | Patrick Burnett | Proposed Sale | 6,287 | $25.18 | $158.3K | — | View → |
| Mar 2, 2026 | Mar 2 10:59 PM | Keith Leonard | Proposed Sale | 39,272 | $25.39 | $997.2K | — | View → |
| Mar 2, 2026 | Mar 2 10:25 PM | Howard Welgus | Proposed Sale | 10,000 | $25.65 | $256.5K | — | View → |
| Feb 2, 2026 | Feb 5 1:35 AM | Masaru MatsudaReporting Person's title: SVP General Counsel and Corporate Secretary | Sale | 40,638 | $25.28 | $1.0M | 110,003(D) | View → |
| Feb 4, 2026 | Feb 5 12:30 AM | Patrick BurnettReporting Person's Title: Executive Vice President and Chief Medical Officer | Sale | 9,794 | $25.81 | $252.7K | 80,651(D) | View → |
| Feb 2, 2026 | Feb 5 12:30 AM | Patrick BurnettReporting Person's Title: Executive Vice President and Chief Medical Officer | Sale | 3,675 | $25.50 | $93.7K | 90,445(D) | View → |
| Feb 2, 2026 | Feb 5 12:25 AM | Todd WatanabeDirector, Reporting Person's title: President and Chief Executive Officer | Sale | 19,833 | $25.50 | $505.7K | 721,306(D) | View → |
| Feb 2, 2026 | Feb 5 12:24 AM | Latha VairavanSVP Chief Financial Officer | Sale | 1,320 | $25.50 | $33.7K | 63,607(D) | View → |
| Feb 2, 2026 | Feb 5 12:23 AM | Howard G. WelgusDirector | Sale | 10,000 | $25.05 | $250.5K | 59,744(D) | View → |
| Feb 2, 2026 | Feb 5 12:21 AM | Larry Todd EdwardsReporting Person's title: EVP Chief Commercial Officer | Sale | 2,052 | $25.50 | $52.3K | 148,865(D) | View → |
| Feb 4, 2026 | Feb 4 9:52 PM | Patrick Burnett | Proposed Sale | 9,794 | $25.81 | $252.7K | — | View → |
| Feb 2, 2026 | Feb 2 11:19 PM | Masaru Matsuda | Proposed Sale | 40,638 | $25.28 | $1.0M | — | View → |
| Feb 2, 2026 | Feb 2 11:17 PM | Todd Edwards | Proposed Sale | 2,052 | $25.50 | $52.3K | — | View → |
| Feb 2, 2026 | Feb 2 11:15 PM | Latha Vairavan | Proposed Sale | 1,320 | $25.50 | $33.7K | — | View → |
| Feb 2, 2026 | Feb 2 10:48 PM | Patrick Burnett | Proposed Sale | 3,675 | $25.50 | $93.7K | — | View → |
| Feb 2, 2026 | Feb 2 10:41 PM | Todd Frank Watanabe | Proposed Sale | 19,833 | $25.50 | $505.7K | — | View → |
| Feb 2, 2026 | Feb 2 10:04 PM | Howard Welgus | Proposed Sale | 10,000 | $25.05 | $250.5K | — | View → |
| Jan 5, 2026 | Jan 5 9:01 PM | Patrick Burnett | Proposed Sale | 2,490 | $28.98 | $72.2K | — | View → |
| Jan 2, 2026 | Jan 2 9:00 PM | Howard Welgus | Proposed Sale | 10,000 | $28.96 | $289.6K | — | View → |
| Dec 31, 2025 | Dec 31 9:01 PM | Patrick Burnett | Proposed Sale | 1,697 | $29.21 | $49.6K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Mar 4 1:42 AM | Masaru MatsudaReporting Person's title: EVP, Chief Legal Officer | Grant/Award | 97,000 | $26.97 | 97,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:42 AM | Latha VairavanSVP Chief Financial Officer | Grant/Award | 70,000 | $26.97 | 70,000(D) | View → |
| Feb 27, 2026 | Mar 4 1:41 AM | Patrick BurnettReporting Person's title: EVP, Chief Medical Officer | Grant/Award | 77,000 | $26.97 | 77,000(D) | View → |
← Previous
Page 2 of 2